Zogenix (ZGNX) Misses Q3 EPS by 75c

Go back to Zogenix (ZGNX) Misses Q3 EPS by 75c

Zogenix Provides Corporate Update and Reports Third Quarter 2017 Financial Results

November 7, 2017 4:01 PM EST

During the third quarter, the Company announced positive top-line results from its Phase 3 Study 1 of ZX008 in patients with Dravet syndromeStudy 1 met primary endpoint of reduction in frequency of convulsive seizures (p... More